Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John B. Harlow Jr currently holds 800,000 shares of Esperion Therapeutics, Inc. (ESPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John B. Harlow Jr has been a net neutral trader of ESPR stock. They have purchased $0 and sold $0 worth of shares.
John B. Harlow Jr's most recent insider trade was on Sep 29, 2026, when they sold 800,000 shares at $0.00 per share.
John B. Harlow Jr serves as Executive at Esperion Therapeutics, Inc. (ESPR). They have executed 3 insider transactions totaling $0 over their tenure at the company.
John B. Harlow Jr holds the position of Executive at Esperion Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
John B. Harlow Jr has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by John B. Harlow Jr was on Sep 29, 2026, when they purchased $0 worth of LRMR shares. This transaction involved 800,000 shares at N/A per share.
John B. Harlow Jr currently owns 800,000 shares of Esperion Therapeutics, Inc. (ESPR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John B. Harlow Jr's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John B. Harlow Jr has 3 Form 4 filings on record as an insider at Esperion Therapeutics, Inc..
Set alerts for John B. Harlow Jr and 40,000+ other insiders.